J E Wells1, F Berr, L A Thomas, R H Dowling, P B Hylemon. 1. Department of Microbiology and Immunology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond 23298-0678, USA.
Abstract
BACKGROUND/AIMS: The development of cholesterol gallstones, in some patients, has been associated with increased proportions of deoxycholic acid in the bile acid pool. Deoxycholic acid is a microbial product of cholic acid 7alpha-dehydroxylation in the intestines. The levels and activities of bile acid 7alpha-dehydroxylating bacteria have been reported to be increased in gallstone patients. The aim of the current study was to isolate 7alpha-dehydroxylating bacteria from gallstone patients and determine if these individuals are colonized by similar bacterial species. METHODS: The levels of 7alpha-dehydroxylating bacteria in fecal samples were determined by fecal dilutions in 24 gallstone patients and 10 controls. 7alpha-Dehydroxylating bacteria were isolated by a non-selective streak plate technique and 7alpha-dehydroxylation activity was determined by measuring the conversion of [14C]-cholic acid to [14C]-deoxycholic acid using thin-layer chromatography. RESULTS: Gallstone patients had >42-fold (p<0.01) higher levels of 7alpha-dehydroxylating bacteria than patients who had not developed gallstones. Eighteen strains of 7alpha-dehydroxylating bacteria were isolated from eight gallstone patients. Attempts to isolate 7alpha-dehydroxylating bacteria from ten control patients were unsuccessful using identical isolation techniques. Surprisingly, all strains of bacteria isolated from gallstone patients appear to belong to the genus Clostridium. CONCLUSION: Gallstone patients have higher levels of 7alpha-dehydroxylating fecal bacteria and appear to harbor only members of the genus Clostridium with this activity.
BACKGROUND/AIMS: The development of cholesterol gallstones, in some patients, has been associated with increased proportions of deoxycholic acid in the bile acid pool. Deoxycholic acid is a microbial product of cholic acid 7alpha-dehydroxylation in the intestines. The levels and activities of bile acid 7alpha-dehydroxylating bacteria have been reported to be increased in gallstonepatients. The aim of the current study was to isolate 7alpha-dehydroxylating bacteria from gallstonepatients and determine if these individuals are colonized by similar bacterial species. METHODS: The levels of 7alpha-dehydroxylating bacteria in fecal samples were determined by fecal dilutions in 24 gallstonepatients and 10 controls. 7alpha-Dehydroxylating bacteria were isolated by a non-selective streak plate technique and 7alpha-dehydroxylation activity was determined by measuring the conversion of [14C]-cholic acid to [14C]-deoxycholic acid using thin-layer chromatography. RESULTS:Gallstonepatients had >42-fold (p<0.01) higher levels of 7alpha-dehydroxylating bacteria than patients who had not developed gallstones. Eighteen strains of 7alpha-dehydroxylating bacteria were isolated from eight gallstonepatients. Attempts to isolate 7alpha-dehydroxylating bacteria from ten control patients were unsuccessful using identical isolation techniques. Surprisingly, all strains of bacteria isolated from gallstonepatients appear to belong to the genus Clostridium. CONCLUSION:Gallstonepatients have higher levels of 7alpha-dehydroxylating fecal bacteria and appear to harbor only members of the genus Clostridium with this activity.
Authors: Eva Beuling; Ilona M Kerkhof; Grace A Nicksa; Michael J Giuffrida; Jamie Haywood; Daniel J aan de Kerk; Christina M Piaseckyj; William T Pu; Terry L Buchmiller; Paul A Dawson; Stephen D Krasinski Journal: Gut Date: 2010-07 Impact factor: 23.059
Authors: Lindsey K Ly; Joe L Rowles; Hans Müller Paul; João M P Alves; Camdon Yemm; Patricia M Wolf; Saravanan Devendran; Matthew E Hudson; David J Morris; John W Erdman; Jason M Ridlon Journal: J Steroid Biochem Mol Biol Date: 2019-12-20 Impact factor: 4.292
Authors: Jason M Ridlon; Saravanan Devendran; João Mp Alves; Heidi Doden; Patricia G Wolf; Gabriel V Pereira; Lindsey Ly; Alyssa Volland; Hajime Takei; Hiroshi Nittono; Tsuyoshi Murai; Takao Kurosawa; George E Chlipala; Stefan J Green; Alvaro G Hernandez; Christopher J Fields; Christy L Wright; Genta Kakiyama; Isaac Cann; Purna Kashyap; Vance McCracken; H Rex Gaskins Journal: Gut Microbes Date: 2019-06-09
Authors: Saravanan Devendran; Rachana Shrestha; João M P Alves; Patricia G Wolf; Lindsey Ly; Alvaro G Hernandez; Celia Méndez-García; Ashley Inboden; J'nai Wiley; Oindrila Paul; Avery Allen; Emily Springer; Chris L Wright; Christopher J Fields; Steven L Daniel; Jason M Ridlon Journal: Appl Environ Microbiol Date: 2019-03-22 Impact factor: 4.792
Authors: Alexander Khoruts; Michael J Sadowsky; Christopher Staley; Alexa R Weingarden Journal: Appl Microbiol Biotechnol Date: 2016-11-25 Impact factor: 4.813
Authors: Michael Kriss; Keith Z Hazleton; Nichole M Nusbacher; Casey G Martin; Catherine A Lozupone Journal: Curr Opin Microbiol Date: 2018-07-20 Impact factor: 7.934
Authors: Junhai Ou; Franck Carbonero; Erwin G Zoetendal; James P DeLany; Mei Wang; Keith Newton; H Rex Gaskins; Stephen J D O'Keefe Journal: Am J Clin Nutr Date: 2013-05-29 Impact factor: 7.045